Format

Send to

Choose Destination
Brain Pathol. 2019 May;29(3):321-324. doi: 10.1111/bpa.12709. Epub 2019 Feb 1.

Oncogenic KRAS hotspot mutations are rare in IDH-mutant gliomas.

Author information

1
Center for CNS Tumors, Comprehensive Cancer Center Tuebingen-Stuttgart, University Hospital of Tuebingen, Eberhard Karls University of Tuebingen, Tuebingen, Germany.
2
Department of Neuropathology, Institute of Pathology and Neuropathology, University Hospital of Tuebingen, Eberhard Karls University of Tuebingen, Tuebingen, Germany.
3
Interdisciplinary Division of Neurooncology, Departments of Vascular Neurology & Neurosurgery University Hospital of Tuebingen, Eberhard Karls University of Tuebingen, Hertie-Institute for Clinical Brain Research, Tuebingen, Germany.
4
Department of Neurosurgery, University Hospital of Tuebingen, Eberhard Karls University Tuebingen, Tuebingen, Germany.
5
Department of Radiation Oncology, University Hospital of Tuebingen, Eberhard Karls University of Tuebingen, Tuebingen, Germany.
6
German Consortium for Translational Cancer Research (DKTK), DKFZ partner site Tuebingen, Tuebingen, Germany.
7
CeGaT GmbH and Praxis für Humangenetik Tuebingen, Tuebingen, Germany.
8
Center for Personalized Medicine, Eberhard Karls University of Tuebingen, Tuebingen, Germany.
PMID:
30676672
DOI:
10.1111/bpa.12709
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center